Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Diabetes Metab ; 38(6): 574-5, 2012 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-23041442

RESUMO

Sleepwalking (somnambulism) is a sleep disorder classified as a parasomnia. Sleepwalkers develop motor activities that may be simple or complex: they can get out of bed, walk, urinate and even leave the house while remaining unconscious and unable to communicate. It is difficult to wake a sleepwalker, but it is not dangerous - as many people think. Sleepwalking cases have been caused by jet lag, the consumption of narcotics, sedatives and alcohol, cardiac problems such as arrhythmias, and other medical conditions, including epilepsy, asthma and apnoea. In a quick search of the literature, only one case due to hypoglycaemia has been reported, describing a patient with type 1 diabetes whose sleepwalking was triggered by nocturnal hypoglycaemia. Our present case was similar, and our report also describes how it occurred and how the condition was remedied.


Assuntos
Hipoglicemia/complicações , Sonambulismo/sangue , Adulto , Glicemia/metabolismo , Diabetes Mellitus Tipo 1/sangue , Humanos , Masculino
2.
Pediatr Neurol ; 42(4): 249-54, 2010 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-20304327

RESUMO

Children with epilepsy have high rates of sleep problems. Melatonin has been advocated in treatment of sleep disorders, and its beneficial effect has been confirmed in insomnia. The aim of this study was to assess melatonin levels in children with intractable epilepsy and its relation to pattern of sleep and characteristics of seizure disorder, as well as the effect of melatonin therapy on those parameters. The study was conducted on 23 children with intractable epilepsy and 14 children with controlled seizures. Patients were evaluated by psychometric sleep assessment and assay of diurnal and nocturnal melatonin levels. Children with intractable epilepsy received oral melatonin before bedtime. They were reassessed after 3 months. Children with intractable epilepsy had higher scores for each category of sleep walking, forcible teeth grinding, and sleep apnea. At the end of therapeutic trial, patients with intractable epilepsy exhibited significant improvement in bedtime resistance, sleep duration, sleep latency, frequent nocturnal arousals, sleep walking, excessive daytime sleepiness, nocturnal enuresis, forcible teeth grinding, sleep apnea, and Epworth sleepiness scores. There was also significant reduction in seizure severity. Thus, use of melatonin in patients with intractable seizures was associated with improvement of both many sleep-related phenomena and the severity of seizures.


Assuntos
Epilepsia/tratamento farmacológico , Hipnóticos e Sedativos/uso terapêutico , Melatonina/uso terapêutico , Convulsões/tratamento farmacológico , Transtornos do Sono-Vigília/tratamento farmacológico , Adolescente , Bruxismo/sangue , Bruxismo/tratamento farmacológico , Criança , Pré-Escolar , Epilepsia/sangue , Feminino , Humanos , Masculino , Melatonina/sangue , Fotoperíodo , Psicometria , Convulsões/sangue , Índice de Gravidade de Doença , Sono/efeitos dos fármacos , Sono/fisiologia , Síndromes da Apneia do Sono/sangue , Síndromes da Apneia do Sono/tratamento farmacológico , Transtornos do Sono-Vigília/sangue , Sonambulismo/sangue , Sonambulismo/tratamento farmacológico , Fatores de Tempo , Resultado do Tratamento
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...